Evidence map›Paper›PMID 31076725›Full record

ArticleCellular & molecular immunology2020

TRAF3IP3 at the trans-Golgi network regulates NKT2 maturation via the MEK/ERK signaling pathway.

Xinwei Zhang, Ke Wang, Weijia Zhao, Li Cao, Shusong Zhang, Rong Jin, Xiuyuan Sun, Jie Hao, Xiaojun Huang, Mingzhao Zhu and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Xinwei ZhangDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China.
Ke WangDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China.
Weijia ZhaoDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China.
Li CaoDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China.
Shusong ZhangDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China.
Rong JinDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China.
Xiuyuan SunDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China.
Jie HaoDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China.
Xiaojun HuangBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital & Institute of Hematology, Beijing, 100044, China.
Mingzhao ZhuKey Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.ORCID http://orcid.org/0000-0003-2001-2669
Hounan WuPeking University Medical and Health Analytical Center, Peking University Health Science Center, Beijing, 100191, China. wuhounan@bjmu.edu.cn.
Hongshan ZhaoDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China. hongshan@bjmu.edu.cn.
Qing GeDepartment of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, 100191, China. qingge@bjmu.edu.cn.
Peking University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thymic natural killer T (NKT)2 cells are a subset of invariant NKT cells with PLZF

Indexed as

Cell DifferentiationMAP Kinase Signaling SystemAnimalsCarrier ProteinsCell ProliferationCellular MicroenvironmentEnzyme ActivationHEK293 CellsHumansMembrane ProteinsMice, Inbred C57BLMice, KnockoutMitogen-Activated Protein Kinase KinasesNatural Killer T-CellsThymus Glandtrans-Golgi NetworkCarrier ProteinsMembrane ProteinsMitogen-Activated Protein Kinase KinasesTRAF3IP3 protein, mouseFunctional maturationMEK/ERK signalingNKT2 cellsTRAF3IP3

Identifiers

PMID31076725
PMCPMC7109081
OpenAlexW2944399758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.